ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Natco Pharma launches additional strengths of generic version of Revlimid in US
Natco Pharma Ltd on Friday said it has launched additional strengths for its generic lenalidomide capsules used in the treatment of multiple myeloma, in the US. The company has launched 2.
Announcement as on 10 March 2023

Gainers and Losers: PSBs, Natco Pharma among stocks in spotlight on Friday
The Sensex jumped nearly 900 points and the Nifty rallied over 272 points on Friday, bouncing back from the previous day's fall, following a positive trend in global equities and fresh foreign fund inflows.
Announcement as on 03 March 2023

Natco Pharma stock up for second day on share buyback plan
The board of directors will on March 8 consider a proposal for the buyback of fully paid-up equity shares of the company of face value of Rs 2 each
Announcement as on 03 March 2023

Natco Pharma jumps 4% on filing generic version of oncology drug in US
The drug major filed an abbreviated new drug application (ANDA) for generic versions of Olaparib tablets - 100 mg and 150 mg with the US Food and Drug Administration (USFDA)
Announcement as on 13 February 2023

Natco Pharma submits application with USFDA for generic cancer drug
The company has submitted an Abbreviated New Drug Application (ANDA) containing a 'paragraph IV' certification with the US Food and Drug Administration (FDA) for the product, a generic version of AstraZeneca's Olaparib tablets in strengths of 100mg and 150
Announcement as on 13 February 2023

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 941.55
  • 12Day Average: 914.44
  • 20Day Average: 891.75
  • 50Day Average: 1020.48
  • 100Day Average: 996.81
  • 150Day Average: 959.53
  • 200Day Average: 927.42

524816 Indicators & signals

Indicator MACD (12,26,9)

925.34, 940.66, -33.18
Indicator MACD is in negative zone

Indicator ADX (14)

27.45, 29.83, 16.98
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 46
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
07 Tue Jul 2026 984.35 924.65 to 988.80 5.55% 1.59 times
03 Fri Jul 2026 932.60 927.35 to 939.20 -0.13% 0.28 times
02 Thu Jul 2026 933.80 922.45 to 939.50 0.93% 0.59 times
01 Wed Jul 2026 925.15 916.10 to 951.00 -0.72% 1.43 times
30 Tue Jun 2026 931.85 915.25 to 934.75 1.41% 0.46 times
29 Mon Jun 2026 918.85 890.50 to 924.00 1.7% 0.82 times
25 Thu Jun 2026 903.45 894.95 to 918.10 1.06% 1.88 times
24 Wed Jun 2026 893.95 890.00 to 913.35 0.11% 1.22 times
23 Tue Jun 2026 892.95 885.25 to 913.00 0.97% 2.35 times
22 Mon Jun 2026 884.35 881.80 to 892.75 -0.5% 0.26 times
19 Fri Jun 2026 888.75 877.00 to 909.00 0.62% 0.72 times
18 Thu Jun 2026 883.25 862.80 to 895.80 1.86% 1.96 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top